Germany's second-largest health insurer accepts exoskeleton prejudice as direct occupational disability compensation

ReWalk Robotics Ltd (Nasdaq: RWLK) ("ReWalk" or the "Company"), today welcomed BARpriMER's decision not to accept the ruling. A state court ruled that exoskeletons qualify as direct disability compensation, withdrawing a case pending at the federal level shortly before trial. The result is that a qualified insured with paraplegia (QSL) in Germany, the largest market for ReWalk's exoskeletons, has a legal basis to provide an exoskeleton as an orthopedic device for direct disability compensation.

In the precedent-setting decision, the court held that an exoskeleton device directly compensates a person with spinal cord injury for the ability to stand, walk, and climb or descend stairs and obstacles. The definition of direct disability compensation applies to medical devices that replace failed and impaired bodily functions and whose users are equal to people without disabilities qualified insured regardless of other medical devices previously provided.

"The successful outcome of this legal challenge to recognize the exoskeleton as direct disability compensation changes the landscape of eligible paraplegics," said Larry Jasinski, CEO of ReWalk. "The German healthcare system has led the way in adopting exoskeletons for individuals with spinal cord injuries. We expect that the adoption of the prior ruling will help medically qualified members of the SCI community access exoskeleton technology in a more efficient manner."

"We expect today's events to be significant for people with disabilities in Germany. The state court precedent is enforceable and legally binding and will help ensure that eligible people with spinal paralysis have a legal basis for accessing this technology," said Professor Thomas Ratajczak, the legal representative of the plaintiff in the case.

Plaintiff Lars Winken said, "After waiting seven years to walk in an exoskeleton, I am pleased that Parmer is now offering me another walk. It's important to know that other people with disabilities will now have easy access to this technology. Getting an exoskeleton and being able to get up and walk at any time opens up new horizons for me.

About ReWalk Robotics Ltd
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities resulting from SCI or stroke. ReWalk's mission is to fundamentally change the quality of life for people with lower limb disabilities by designing and developing market-leading robotic technologies. ReWalk was founded in 2001 and has headquarters in the USA, Israel and Germany.

ReWalk® and ReStore® are trademarks of ReWalk Robotics Ltd. in the United States and other jurisdictions. are registered trademarks of

Forward-looking statements

In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act . 1934 Revised. Such forward-looking statements include statements other than statements of future performance and historical facts of Revok and may in some cases be identified by words such as "expect," "estimate," "believe," "continue." "may," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "plan," "future," "will," "should . ", "seek" and similar words or expressions. Forward-looking statements in this press release are based on management's current expectations, which are subject to uncertainties, risks and changes in circumstances that are difficult to predict, many of which are beyond ReWalk's control. Important factors that could cause ReWalk's actual results to differ materially from those expressed in the forward-looking statements are discussed in detail in ReWalk's periodic filings with the Securities and Exchange Commission ("SEC"), including the risk factors described under the heading "Risk." . Factors in ReWalk's Annual Report on Forms 10-K and 10-K/A for the year ended December 31, 2021 filed with the SEC and other documents subsequently filed with or furnished to the SEC. Any forward-looking statement in this press release speaks only as of its date. From time to time, factors or events may arise that could cause ReWalk's actual results to differ from those indicated herein, and it is impossible for ReWalk to predict all of them. Except as required by law, ReWalk undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Source: Germany's second-largest health insurer withdraws appeal to Federal Social Court, accepts exoskeleton prejudice as direct occupational disability compensation (kreuznacher-rundschau.de) (14.11.2022)